Henning Nilius

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Acute Myeloid Leukemia

Stem Cell Transplantation

Top Venues

Current oncology (Toronto, Ont.)

Current issues in molecular biology

This page only lists publications with an associated author ORCID identifier.

Publications

Katja Seipel, Nuria Z Veglio, Henning Nilius, Barbara Jeker, Vera Ulrike Bacher, Thomas Pabst
Rising Prevalence of Low-Frequency PPM1D Gene Mutations after Second HDCT in Multiple Myeloma. Current issues in molecular biology 46 (8) (2024)
Katja Seipel, Nuria Z Veglio, Henning Nilius, Barbara Jeker, Vera Ulrike Bacher, Thomas Pabst
Rising Prevalence of Low-Frequency PPM1D Gene Mutations after Second HDCT in Multiple Myeloma. Current issues in molecular biology 46 (8) (2024)
Matthias Eggimann, Dilara Akhoundova, Henning Nilius, Michèle Hoffmann, Michael Hayoz, Yolanda Aebi, Carlo R Largiadèr, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation. Cancers 16 (10) (2024)
Katja Seipel, Nuria Z Veglio, Henning Nilius, Barbara Jeker, Vera Ulrike Bacher, Thomas Pabst
Rising Prevalence of Low-Frequency PPM1D Gene Mutations after Second HDCT in Multiple Myeloma. Current issues in molecular biology 46 (8) (2024)
Matthias Eggimann, Dilara Akhoundova, Henning Nilius, Michèle Hoffmann, Michael Hayoz, Yolanda Aebi, Carlo R Largiadèr, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation. Cancers 16 (10) (2024)
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Vera Ulrike Bacher, Thomas Pabst
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology (Toronto, Ont.) 30 (12) (2023)
Katja Seipel, Mariesol Abbühl, Vera Ulrike Bacher, Henning Nilius, Michael Daskalakis, Thomas Pabst
Clinical Impact of Single Nucleotide Polymorphism in CD-19 on Treatment Outcome in FMC63-CAR-T Cell Therapy. Cancers 15 (11) (2023)
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Vera Ulrike Bacher, Thomas Pabst
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology (Toronto, Ont.) 30 (12) (2023)
Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules 13 (2) (2023)
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Vera Ulrike Bacher, Thomas Pabst
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology (Toronto, Ont.) 30 (12) (2023)
Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules 13 (2) (2023)
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Vera Ulrike Bacher, Thomas Pabst
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology (Toronto, Ont.) 30 (12) (2023)
Sonja Hartnack, Henning Nilius, Sabrina Jegerlehner, Franziska Suter-Riniker, Pascal Bittel, Philipp Jent, Michael Nagler
Determination of the Diagnostic Performance of Laboratory Tests in the Absence of a Perfect Reference Standard: The Case of SARS-CoV-2 Tests. Diagnostics (Basel, Switzerland) 13 (18) (2023)
Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules 13 (2) (2023)
Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules 13 (2) (2023)
Michael Nagler, Henning Nilius
Next-generation diagnostic instruments in haematology. British journal of haematology (2023)
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Vera Ulrike Bacher, Thomas Pabst
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology (Toronto, Ont.) 30 (12) (2023)
Henning Nilius, Jonas Kaufmann, Adam Cuker, Michael Nagler
Comparative effectiveness and safety of anticoagulants for the treatment of heparin-induced thrombocytopenia. American journal of hematology 96 (7) (2021)